NIH clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

 

12/28/2022 11:00 AM EST

ASPS is an extremely rare cancer that affects mostly adolescents and young adults.

This email was sent to linus.stotts.epicblog@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612 GovDelivery logo

Comments

Popular posts from this blog

U.S. Customs and Border Protection Trade Update

U.S. Customs and Border Protection Trade Update

U.S. Customs and Border Protection Media Releases Update